{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:02:04Z","timestamp":1795104124650,"version":"4.10.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of refractory <jats:italic>Mycoplasma pneumoniae<\/jats:italic> (MP) pneumonia has been increasing. However, few studies have investigated the impact of respiratory virus coinfection in patients with MP pneumonia, and their results have been inconclusive. This study aimed to investigate the impact of respiratory virus coinfection in children hospitalized with MP pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study enrolled 145 children hospitalized with MP pneumonia between May 2019 and March 2020. The patients were divided into two groups: the respiratory virus coinfection and non-coinfection groups. All the children underwent polymerase chain reaction testing for respiratory virus infection. Information on clinical, laboratory, and radiologic findings were obtained retrospectively via medical chart reviews.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Children in the respiratory virus coinfection group were younger than those in the non-coinfection group. Respiratory virus coinfection in children hospitalized with MP pneumonia was significantly associated with persistence of fever more than 6 days (adjusted odds ratio [aOR], 2.394; 95% confidence interval [95% CI], 1.172\u20134.892<jats:bold>)<\/jats:bold>, severe pneumonia (aOR, 4.602; 95% CI, 1.154\u201318.353), and poor response to the stepwise approach for MP pneumonia (aOR, 4.354; 95% CI, 1.374\u201313.800). In addition, higher levels of liver enzymes and lactate dehydrogenase at admission were associated with respiratory virus coinfection in children with MP pneumonia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results of this study suggest that respiratory virus coinfection in children hospitalized with MP pneumonia may be associated with refractory MP pneumonia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02005-y","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T11:03:54Z","timestamp":1653908634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Clinical significance of respiratory virus coinfection in children with Mycoplasma pneumoniae pneumonia"],"prefix":"10.1186","volume":"22","author":[{"given":"Soojeong","family":"Choo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"issue":"9","key":"2005_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835\u201345.","journal-title":"N Engl J Med"},{"issue":"1","key":"2005_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12879-020-4810-9","volume":"20","author":"E Lee","year":"2020","unstructured":"Lee E, Kim CH, Lee YJ, Kim HB, Kim BS, Kim HY, Kim Y, Kim S, Park C, Seo JH, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis. 2020;20(1):132.","journal-title":"BMC Infect Dis"},{"key":"2005_CR3","doi-asserted-by":"crossref","unstructured":"Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol Infect. 2021;54(4):557\u2013565.","DOI":"10.1016\/j.jmii.2020.10.002"},{"issue":"10","key":"2005_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ajic.2020.01.013","volume":"48","author":"J Liu","year":"2020","unstructured":"Liu J, Wang M, Zhao Z, Lin X, Zhang P, Yue Q, Zhang T, Meng Y. Viral and bacterial coinfection among hospitalized children with respiratory tract infections. Am J Infect Control. 2020;48(10):1231\u201336.","journal-title":"Am J Infect Control"},{"issue":"4","key":"2005_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/00006454-200004000-00006","volume":"19","author":"T Juven","year":"2000","unstructured":"Juven T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, Eskola J, Saikku P, Ruuskanen O. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19(4):293\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"2005_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","volume":"7","author":"S Pereyre","year":"2016","unstructured":"Pereyre S, Goret J, Bebear C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974.","journal-title":"Front Microbiol"},{"issue":"5","key":"2005_CR7","doi-asserted-by":"publisher","first-page":"e0156465","DOI":"10.1371\/journal.pone.0156465","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z: The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children. PLoS One 2016, 11(5):e0156465.","journal-title":"PLoS One"},{"key":"2005_CR8","unstructured":"de Sant\u00e9 HA. Medical compression in chronic venous conditions. Ann Dermatol Venereol. 2013;140(5):393\u201396."},{"issue":"4","key":"2005_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.24684","volume":"55","author":"S Cheng","year":"2020","unstructured":"Cheng S, Lin J, Zheng X, Yan L, Zhang Y, Zeng Q, Tian D, Fu Z, Dai J. Development and validation of a simple-to-use nomogram for predicting refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2020;55(4):968\u2013974.","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"2005_CR10","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.4187\/respcare.03920","volume":"60","author":"A Lu","year":"2015","unstructured":"Lu A, Wang C, Zhang X, Wang L, Qian L. Lactate dehydrogenase as a biomarker for prediction of refractory Mycoplasma pneumoniae pneumonia in children. Respir Care. 2015;60(10):1469\u201375.","journal-title":"Respir Care"},{"issue":"1","key":"2005_CR11","doi-asserted-by":"publisher","first-page":"12934","DOI":"10.1038\/s41598-017-13292-5","volume":"7","author":"M Yang","year":"2017","unstructured":"Yang M, Meng F, Wang K, Gao M, Lu R, Li M, Zhao F, Huang L, Zhang Y, Cheng G, et al. Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children. Sci Rep. 2017;7(1):12934.","journal-title":"Sci Rep"},{"issue":"6","key":"2005_CR12","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3201\/eid2706.203206","volume":"27","author":"MM Lanata","year":"2021","unstructured":"Lanata MM, Wang H, Everhart K, Moore-Clingenpeel M, Ramilo O, Leber A. Macrolide-resistant Mycoplasma pneumoniae infections in children, Ohio, USA. Emerg Infect Dis. 2021;27(6):1588\u201397.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2005_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12879-019-4426-0","volume":"19","author":"MC Zhao","year":"2019","unstructured":"Zhao MC, Wang L, Qiu FZ, Zhao L, Guo WW, Yang S, Feng ZS, Li GX. Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia. BMC Infect Dis. 2019;19(1):835.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2005_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jmii.2013.06.006","volume":"48","author":"CY Chiu","year":"2015","unstructured":"Chiu CY, Chen CJ, Wong KS, Tsai MH, Chiu CH, Huang YC: Impact of bacterial and viral coinfection on Mycoplasma pneumoniae in childhood community-acquired pneumonia. J Microbiol Immunol Infect. 2015;48(1):51\u201356.","journal-title":"J Microbiol Immunol Infect"},{"issue":"11","key":"2005_CR15","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.21037\/jtd.2018.10.33","volume":"10","author":"JH Kim","year":"2018","unstructured":"Kim JH, Kwon JH, Lee JY, Lee JS, Ryu JM, Kim SH, Lim KS, Kim WY: Clinical features of Mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients. J Thorac Dis. 2018;10(11):6118\u201327.","journal-title":"J Thorac Dis"},{"key":"2005_CR16","doi-asserted-by":"crossref","unstructured":"Lee E, Lee YY. Predictive Factors of the responses to treatment of Mycoplasma pneumoniae Pneumonia. J Clin Med. 2021;10(6):1154.","DOI":"10.3390\/jcm10061154"},{"issue":"4","key":"2005_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.prrv.2010.07.005","volume":"11","author":"GB Fischer","year":"2010","unstructured":"Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010;11(4):233\u201339.","journal-title":"Paediatr Respir Rev"},{"issue":"5","key":"2005_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/17476348.2019.1586537","volume":"13","author":"E Kavaliunaite","year":"2019","unstructured":"Kavaliunaite E, Aurora P. Diagnosing and managing bronchiolitis obliterans in children. Expert Rev Respir Med. 2019;13(5):481\u201388.","journal-title":"Expert Rev Respir Med"},{"issue":"6\u20137","key":"2005_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/00365540902942840","volume":"41","author":"SI Cha","year":"2009","unstructured":"Cha SI, Shin KM, Kim M, Yoon WK, Lee SY, Kim CH, Park JY, Jung TH. Mycoplasma pneumoniae bronchiolitis in adults: clinicoradiologic features and clinical course. Scand J Infect Dis. 2009;41(6\u20137):515\u201319.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"2005_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1148\/radiology.215.1.r00ap22184","volume":"215","author":"W de Monye","year":"2000","unstructured":"de Monye W, van Strijen MJ, Huisman MV, Kieft GJ, Pattynama PM. Suspected pulmonary embolism: prevalence and anatomic distribution in 487 consecutive patients. Advances in New Technologies Evaluating the Localisation of Pulmonary Embolism (ANTELOPE) Group. Radiology. 2000;215(1):184\u201388.","journal-title":"Radiology"},{"issue":"1","key":"2005_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12879-020-05356-1","volume":"20","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Wang J, Chen W, Shen N, Tao Y, Zhao R, Luo L, Li B, Cao Q. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20(1):633.","journal-title":"BMC Infect Dis"},{"key":"2005_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jcv.2018.06.003","volume":"105","author":"AC Nascimento-Carvalho","year":"2018","unstructured":"Nascimento-Carvalho AC, Vilas-Boas AL, Fontoura MH, Vuorinen T, Nascimento-Carvalho CM, Group PN-ES. respiratory viruses among children with non-severe community-acquired pneumonia: a prospective cohort study. J Clin Virol. 2018;105:77\u201383.","journal-title":"J Clin Virol"},{"issue":"1","key":"2005_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12890-019-0990-8","volume":"19","author":"HS Kim","year":"2019","unstructured":"Kim HS, Sol IS, Li D, Choi M, Choi YJ, Lee KS, Seo JH, Lee YJ, Yang HJ, Kim HH. Efficacy of glucocorticoids for the treatment of macrolide refractory Mycoplasma pneumoniae in children: meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19(1):251.","journal-title":"BMC Pulm Med"},{"issue":"10","key":"2005_CR24","first-page":"1246","volume":"12","author":"I Stelmach","year":"2005","unstructured":"Stelmach I, Podsiadlowicz-Borzecka M, Grzelewski T, Majak P, Stelmach W, Jerzynska J, Poplawska M, Dziadek J. Humoral and cellular immunity in children with Mycoplasma pneumoniae infection: a 1-year prospective study. Clin Diagn Lab Immunol. 2005;12(10):1246\u201350.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"9","key":"2005_CR25","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cmi.2020.06.020","volume":"26","author":"JW Yang","year":"2020","unstructured":"Yang JW, Yang L, Luo RG, Xu JF. Corticosteroid administration for viral pneumonia: COVID-19 and beyond. Clin Microbiol Infect. 2020;26(9):1171\u201377.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2005_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0009922816688737","volume":"57","author":"D Jujaray","year":"2018","unstructured":"Jujaray D, Juan LZ, Shrestha S, Ballgobin A. Pattern and significance of asymptomatic elevation of liver enzymes in Mycoplasma pneumoniae in children. Clin Pediatr (Phila). 2018;57(1):57\u201361.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"2005_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5223\/pghn.2016.19.4.243","volume":"19","author":"JS Oh","year":"2016","unstructured":"Oh JS, Choi JS, Lee YH, Ko KO, Lim JW, Cheon EJ, Lee GM, Yoon JM. The relationships between respiratory virus infection and aminotransferase in children. Pediatr Gastroenterol Hepatol Nutr. 2016;19(4):243\u201350.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"1","key":"2005_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12887-021-02523-4","volume":"21","author":"M Tang","year":"2021","unstructured":"Tang M, Wang D, Tong X, Wu Y, Zhang J, Zhang L, Yin Y, Cao Q: Comparison of different detection methods for Mycoplasma pneumoniae infection in children with community-acquired pneumonia. BMC Pediatr. 2021;21(1):90.","journal-title":"BMC Pediatr"},{"issue":"19","key":"2005_CR29","doi-asserted-by":"publisher","first-page":"e3605","DOI":"10.1097\/MD.0000000000003605","volume":"95","author":"SC Lee","year":"2016","unstructured":"Lee SC, Youn YS, Rhim JW, Kang JH, Lee KY: Early serologic diagnosis of Mycoplasma pneumoniae pneumonia: an observational study on changes in titers of specific-IgM antibodies and cold agglutinins. Medicine (Baltimore). 2016;95(19):e3605.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2005_CR30","doi-asserted-by":"publisher","first-page":"e0230338","DOI":"10.1371\/journal.pone.0230338","volume":"15","author":"SH Yoon","year":"2020","unstructured":"Yoon SH, Min IK, Ahn JG. Immunochromatography for the diagnosis of Mycoplasma pneumoniae infection: a systematic review and meta-analysis. PLoS One. 2020;15(3):e0230338.","journal-title":"PLoS One"},{"issue":"5","key":"2005_CR31","doi-asserted-by":"publisher","first-page":"e1001444","DOI":"10.1371\/journal.pmed.1001444","volume":"10","author":"EB Spuesens","year":"2013","unstructured":"Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, Weber F, Moll HA, Broekman B, Berger MY, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444.","journal-title":"PLoS Med"},{"issue":"2","key":"2005_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","volume":"50","author":"S Suzuki","year":"2006","unstructured":"Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, Matsuoka M, Kenri T, Arakawa Y, Sasaki T. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50(2):709\u201312.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2005_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ppul.22851","volume":"49","author":"Z Ma","year":"2014","unstructured":"Ma Z, Zheng Y, Deng J, Ma X, Liu H. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China. Pediatr Pulmonol. 2014;49(7):695\u2013700.","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"2005_CR34","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1128\/AAC.00737-13","volume":"57","author":"N Miyashita","year":"2013","unstructured":"Miyashita N, Akaike H, Teranishi H, Ouchi K, Okimoto N. Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrob Agents Chemother. 2013;57(10):5181\u201385.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02005-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T11:06:23Z","timestamp":1653908783000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02005-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"assertion":[{"value":"26 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the Declaration of Helsinki and approved by the institutional review board of the Chonnam National University Hospital, South Korea, along with the institutional review boards of all participating institutions.  Ethics committee of Chonnam National University Hospital waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest with regard to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}